EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction

Wan Gi Byun iD, Minha Lee, Meehyun Ko, Ji Hyae Lee, Sihyeong Yi, JinAh Lee, Seungtaek Kim, Seung Bum Park iD

Angewandte Chemie International Edition · 18.11.2024 · 63 (47)

DOI: 10.1002/anie.202405472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 17.10.2024. Verfasst von Wan Gi Byun und 7 weiteren Autor:innen. Beteiligte Einrichtung: CRI Center for Chemical Proteomics, Department of Chemistry, Seoul National University, 08826, Seoul, Korea. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2, Viral Nonstructural Proteins, RNA, Viral. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The ongoing global threats posed by COVID‐19 pandemic, catalyzed by SARS‐CoV‐2, underscores the pressing need for effective antiviral strategies. The viral non‐structural protein 1 (Nsp1) significantly influences pathogenicity by impeding host protein expression and enhancing viral RNA translation through its interaction with the stem‐loop 1 (SL1) in the 5′ untranslated region (UTR). We have developed a novel dual‐luciferase reporter assay, designed to investigate the critical Nsp1–SL1 interaction, and identified P23E02 as a potential inhibitor. Our investigation, combining molecular docking studies and alanine mutagenesis, has unveiled that P23E02 disrupts Nsp1–40S ribosomal subunit interaction, liberating translational inhibition and empowering host antiviral responses. P23E02 exhibits antiviral efficacy against various sarbecoviruses, making it a promising candidate for combatting COVID‐19 and related diseases. This study underscores the therapeutic potential of targeting the Nsp1/SL1 axis and lays the foundation for innovative antiviral interventions, ultimately fortifying global preparedness against future viral threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2Viral Nonstructural ProteinsRNA, ViralMolecular Docking SimulationHumansCOVID-19 Drug Treatment5' Untranslated Regions

Stichwörter der Autor:innen

Antiviral AgentsNon-Structural Protein 1Protein–RNA InteractionSARS-CoV-2Sarbecovirus

Substanzen

Antiviral AgentsViral Nonstructural ProteinsRNA, Viral5' Untranslated RegionsORF1ab polyprotein, SARS-CoV-2

Autor:innen und Institutionen

  • CRI Center for Chemical Proteomics, Department of Chemistry, Seoul National University, 08826, Seoul, Korea.
  • Zoonotic Virus Laboratory, Institut Pasteur Korea, 13488, Seongnam, Korea.

ORCID-Profile: Wan Gi Byun, Seung Bum Park

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Gi Byun, W., Lee, M., Ko, M., Hyae Lee, J., Yi, S., Lee, J., Kim, S., & Bum Park, S. (2024). Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction. Angewandte Chemie International Edition, 63(47). https://doi.org/10.1002/anie.202405472

Vancouver

Gi Byun W, Lee M, Ko M, Hyae Lee J, Yi S, Lee J, et al. Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction. Angewandte Chemie International Edition. 2024;63(47). doi:10.1002/anie.202405472

BibTeX
@article{GiByun2024,
  author = {Gi Byun, Wan and Lee, Minha and Ko, Meehyun and Hyae Lee, Ji and Yi, Sihyeong and Lee, JinAh and Kim, Seungtaek and Bum Park, Seung},
  title = {Broad‐Spectrum Antiviral Agents against SARS‐CoV‐2 Variants Inhibit the Conserved Viral Protein Nsp1–RNA Interaction},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {47},
  doi = {10.1002/anie.202405472}
}
Kostenlos starten →